Evaluation of MUSA-3 in Microsurgical Anastomoses

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMicrosure

About this trial

This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.

Eligibility criteria

Qualifiers

Patient age ≥ 18 years.

Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery.

Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU.

Able to give informed consent before participating in the study.

Disqualifiers

Subject participates in a potentially confounding drug or device trial during the course of the study.

Patients that are pregnant or breastfeeding.

≥ISL (International Society of Lymphology) Stage III lymphedema

History of marcaine or indocyanine green allergy

Trial design

Treatments tested in this trial

  • Robot-assisted microsurgical anastomoses

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators